Pharmacolog i Uppsala AB

Equities

PERP B

SE0019071812

Advanced Medical Equipment & Technology

Delayed Nasdaq Stockholm Other stock markets 04:00:16 2024-05-03 am EDT			5-day change	1st Jan Change
0.0892 ^SEK	+7.21%		-8.04%	+57.60%

Apr. 24	Perpetua Medical AB Appoints Camilla Lonn as CFO	CI
Apr. 23	Pharmacolog i Uppsala AB will Change its Ticker to PERP B from PHLOG B	CI

Pharmacolog publishes annual report for 2023

April 16, 2024 at 09:08 am EDT

Pharmacolog i Uppsala AB (publ) announces today that the annual report for the financial year 2023 has been published.

The annual report is attached as a PDF and is available on the company's website:
https://pharmacolog.com/investor-relations-2/financial-reports/ (Swedish only).

For more information contact:

Lars Gusch, CEO

Email: lars.gusch@pharmacolog.com
Phone: +46 70-223 97 72

About Pharmacolog

Pharmacolog (proposed name change to Perpetua Medical AB (publ)) is a medical technology company, headquartered in Uppsala, Sweden. The company's shares (ticker PHLOG B) are traded on Nasdaq First North Stockholm.

The following trademarks are owned and protected by Pharmacolog i Uppsala AB: Pharmacolog™-logo, WasteLog™and Pharmacolog Dashboard™.

Further information regarding the company is available at https://pharmacolog.com/.

The company's Certified Adviser is Mangold Fondkommission AB.

https://news.cision.com/pharmacolog/r/pharmacolog-publishes-annual-report-for-2023,c3962407

https://mb.cision.com/Main/12317/3962407/2735834.pdf

https://news.cision.com/pharmacolog/i/pharmacolog-news-500x388px-100,c3289680

Latest news about Pharmacolog i Uppsala AB

Perpetua Medical AB Appoints Camilla Lonn as CFO	Apr. 24	CI
Pharmacolog i Uppsala AB will Change its Ticker to PERP B from PHLOG B	Apr. 23	CI
Pharmacolog i Uppsala AB will Change its Name to Perpetua Medical AB	Apr. 23	CI
Pharmacolog i Uppsala AB Announces the Appointment of Anders Hedlund as Interim CEO, Effective from May 1, 2024	Apr. 04	CI
Pharmacolog Announces Resignation of Lars Gusch as CEO, Effective from April 30, 2024	Mar. 01	CI
Pharmacolog i Uppsala AB Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 16	CI
Pharmacolog i Uppsala AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 15	CI
Pharmacolog AB Terminates the Partnership Agreement with Codonics Inc	Feb. 14	CI
RaySearch Laboratories AB (OM:RAY B) acquired product line Druglog of Pharmacolog AB for SEK 8.5 million.	Feb. 08	CI
Pharmacolog Receives Two DrugLog Orders for Installation in Renews Hospitals in Europe	Jan. 10	CI
Pharmacolog i Uppsala AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 17	CI
Pharmacolog Implements A Strategy with the Main Objective of Carrying Out an Industrial or Financial Sale	23-10-13	CI
Pharmacolog i Uppsala AB Announces New-york-Presbyterian Orders an Additional Wastelog? System	23-09-28	CI
Pharmacolog i Uppsala AB Announces Executive Changes	23-09-27	CI
Pharmacolog i Uppsala AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-25	CI
Renowned Hospitals in the US Select Wastelogâ„¢ to Deter Drug Diversion of Controlled Substances	23-07-07	CI
Pharmacolog i Uppsala AB Announces Board Changes	23-07-05	CI
Pharmacolog I Uppsala AB Upgrade Supports International Expansion	23-06-27	CI
Pharmacolog i Uppsala AB Announces New Platform Available for Sale	23-06-01	CI
Pharmacolog i Uppsala AB Appoints Sofia Uhrbom as Interim Chief Financial Officer	23-05-24	CI
Pharmacolog i Uppsala AB Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-17	CI
Pharmacolog i Uppsala AB Signs Distribution Agreement with B. Braun	23-05-04	CI
Pharmacolog i Uppsala AB Announces CEO Changes	23-05-03	CI
Pharmacolog i Uppsala AB Announces Changes in Board and Management	23-05-03	CI
Pharmacolog i Uppsala AB Announces Björn Varnestigrequests to Be Dismissed from His Position as Chairman of the Board	23-05-02	CI

Chart Pharmacolog i Uppsala AB

Duration

Period

More charts

Company Profile

Perpetua Medical AB (publ), formerly Pharmacolog I Uppsala AB (publ), is a Sweden-based medical technology company that develops systems and solutions which aim to optimize and ensure correct and effective treatment with injectable drugs. The Company provides solutions and products that verifies that drugs and narcotics used in surgery have not been tampered with, its solutions make a vital contribution to preventing drug diversion. Its products Pharmacolog Dashboard offers a variety of valuable tools, generating reports and statistical analyses of validated pharmaceuticals. Another product WasteLog is a device that manages the workflow by instantly analyzing the waste and returns of injectable controlled substances.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-08-28 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Medical Diagnostic & Testing Equipment

	1st Jan change	Capi.
PHARMACOLOG I UPPSALA AB	+57.60%	828K
SARTORIUS AG	-14.77%	18.57B
INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD.	+17.00%	1.85B
SHANGHAI MICROPORT EP MEDTECH CO., LTD.	-0.51%	1.66B
BIOTAGE AB	+26.63%	1.23B
SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD.	-13.90%	989M
CONTEC MEDICAL SYSTEMS CO.,LTD	-21.76%	896M
REVENIO GROUP OYJ	-3.09%	734M
VAREX IMAGING CORPORATION	-19.85%	667M
CELLAVISION AB	+6.13%	498M

Medical Diagnostic & Testing Equipment